Venous Stasis Ulcers
12
0
0
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
8.3%
1 terminated out of 12 trials
90.0%
+3.5% vs benchmark
8%
1 trials in Phase 3/4
44%
4 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (12)
The Effects of Pulsed Elelectro-Magnetic Fields ("PEMF") in the Treatment of Venous Stasis Leg Ulcers
Clinical Evaluation of the SNaP Wound Care System
FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers
V.A.C. VeraFlo™ Instillation Therapy vs V.A.C. Ulta™ Therapy on Biofilm in Chronically Infected Wounds
Wound Fluid Protease Levels During Use of Novel Wound Dressing
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Testing Fish Oil Derivatives In Healing Of Chronic Venous Leg Ulcers
A Post Marketing Clinical Study Utilizing DermaStream and Saline in Venous Ulcers
Taliderm Dressing for Venous Ulcers
Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers
Provant Therapy of Venous Stasis Ulcer Trial
Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers